Metastasis represents one of the most challenging aspects of cancer care, affecting how doctors approach treatment and how patients navigate their journey with the disease. When cancer cells spread from their original location to other parts of the body, the treatment strategy shifts from attempting to cure the disease to managing symptoms, slowing progression, and maintaining the best possible quality of life for as long as possible.

Understanding How Treatment Goals Change When Cancer Spreads

When cancer spreads beyond its original location to distant parts of the body, doctors call this metastasis. This term describes cancer cells that have broken away from the primary tumor and traveled through the bloodstream or lymphatic system to establish new tumors in other organs. Most cancer-related deaths occur because of metastatic disease rather than the original tumor itself.^[4]

The main goal of treating metastatic cancer differs significantly from treating cancer that remains in one place. While early-stage cancers can often be cured with surgery, radiation, or chemotherapy, metastatic cancer is generally considered a systemic disease that affects multiple organs. This means treatment focuses on controlling the disease, managing symptoms, and helping patients live as well as possible for as long as possible.^[5]

Treatment decisions depend on many factors unique to each patient. The type of cancer, where it started, which organs it has spread to, and the patient’s overall health all influence the treatment plan. For instance, breast cancer that spreads to the liver is still treated as breast cancer, not liver cancer, because the cancer cells retain the characteristics of breast tissue.^[2] This distinction matters because it helps doctors choose the most effective therapies.

Medical societies and cancer organizations have established standard treatment approaches based on years of research and clinical experience. At the same time, scientists continue investigating new therapies through clinical trials, offering hope for better outcomes and improved quality of life. These research efforts test innovative molecules, combination therapies, and entirely new treatment strategies that may one day become standard care.^[13]

Standard Treatment Approaches for Metastatic Cancer

Healthcare providers treat metastatic cancer based on where the cancer originally started rather than where it has spread. This approach recognizes that cancer cells maintain characteristics of their tissue of origin even after spreading to new locations. The treatment plan typically involves systemic therapies that can reach cancer cells throughout the body, since metastatic disease is no longer confined to one area.^[5]

Chemotherapy remains a cornerstone of treatment for many types of metastatic cancer. These drugs work by killing rapidly dividing cells or preventing them from multiplying. Chemotherapy travels through the bloodstream, reaching cancer cells wherever they may be in the body. While effective at slowing cancer growth, chemotherapy affects both cancerous and healthy cells, leading to side effects such as nausea, fatigue, hair loss, and increased infection risk. The specific drugs used, their combinations, and treatment schedules vary greatly depending on the cancer type.^[8]

Hormone therapy plays a crucial role for cancers that grow in response to hormones, such as certain breast and prostate cancers. These treatments work by blocking the body’s ability to produce hormones or by interfering with how hormones act on cancer cells. For breast cancer, medications may block estrogen receptors or reduce estrogen production in the body. In prostate cancer, hormone therapy reduces testosterone levels or blocks testosterone from reaching cancer cells. Patients may take these medications for extended periods, sometimes years, to keep the cancer under control.^[21]

Targeted therapies represent a more precise approach to cancer treatment. These drugs identify and attack specific molecules or pathways that cancer cells use to grow and survive. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapies focus on particular abnormalities found in cancer cells. For example, some targeted drugs block growth signals, others prevent blood vessel formation that tumors need, and some mark cancer cells so the immune system can destroy them. Because these treatments are more selective, they often cause fewer side effects than traditional chemotherapy.^[21]

Immunotherapy has emerged as a groundbreaking treatment option for certain metastatic cancers. These therapies help the patient’s own immune system recognize and attack cancer cells. Some immunotherapies remove the “brakes” that prevent immune cells from attacking cancer, while others train immune cells to identify cancer as foreign. Immunotherapy has shown remarkable results in some patients with melanoma, lung cancer, and other types, leading to long-lasting responses. However, not all patients respond to immunotherapy, and these treatments can cause side effects related to an overactive immune system.^[13]

Radiation therapy can treat specific areas where cancer has spread, even in metastatic disease. This approach proves particularly useful when cancer spreads to bones, causing pain or risk of fractures, or when tumors in the brain cause symptoms. Modern radiation techniques allow doctors to deliver high doses of radiation precisely to tumor sites while limiting exposure to healthy tissue. Treatment may involve daily sessions over several weeks or specialized techniques that deliver radiation in just a few sessions.^[14]

For bone metastases specifically, doctors often prescribe bone-building medicines such as bisphosphonates or denosumab. These drugs strengthen bones and reduce the risk of fractures while also helping to control pain. Patients typically receive these medications through an injection every few weeks. These treatments can cause side effects including kidney problems and, rarely, a condition affecting the jawbone called osteonecrosis.^[12]

Radiopharmaceuticals offer another option for bone metastases. These medicines contain low levels of radioactive material that, once injected into a vein, travel to areas of cancer in the bones and deliver radiation directly to those sites. This approach can help relieve pain and reduce the need for stronger pain medications.^[12]

Treatment duration for metastatic cancer varies considerably. Some patients remain on certain therapies indefinitely, as long as they continue working and side effects remain manageable. Others may take breaks from treatment or switch to different therapies if the cancer develops resistance or side effects become intolerable. The goal is always to find the right balance between controlling the cancer and maintaining quality of life.^[16]

Side effects depend on which treatments patients receive. Fatigue appears across most treatment types and can significantly affect daily activities. Nausea and changes in appetite may occur with chemotherapy and some targeted therapies. Skin irritation affects patients receiving radiation. Hormone therapy can cause hot flashes, mood changes, and bone thinning over time. Immunotherapy may lead to inflammation in various organs. Healthcare teams work closely with patients to manage these side effects through supportive medications, lifestyle adjustments, and sometimes modifications to the cancer treatment itself.^[14]

Promising Therapies Being Tested in Clinical Trials

Clinical trials represent the pathway from laboratory discoveries to new cancer treatments. These carefully designed research studies test whether new therapies are safe and effective before they become available as standard treatment options. For people living with metastatic cancer, clinical trials offer access to cutting-edge treatments that may not be available otherwise.^[13]

Clinical trials follow a structured process with distinct phases. Phase I trials primarily evaluate safety, determining the appropriate dose of a new drug and identifying potential side effects in a small group of patients. Phase II trials expand to include more participants and focus on whether the treatment shows evidence of effectiveness against the cancer while continuing to monitor safety. Phase III trials involve hundreds or thousands of patients and compare the new treatment to current standard therapies to determine if the new approach offers better outcomes.^[11]

Antibody-drug conjugates represent an innovative approach gaining significant attention in clinical research. These treatments combine a targeted antibody that seeks out cancer cells with a chemotherapy drug attached to it. The antibody acts like a guided missile, delivering the chemotherapy directly to cancer cells while sparing healthy tissue. Trastuzumab deruxtecan and sacituzumab govitecan exemplify this approach and have shown promising results in clinical trials for breast cancer and other cancers. These drugs have demonstrated the ability to shrink tumors and improve survival in patients whose cancers had stopped responding to other treatments.^[21]

Researchers are exploring new immunotherapy strategies that go beyond current approved treatments. Some experimental approaches combine different types of immunotherapy drugs to attack cancer from multiple angles. Others use modified immune cells taken from the patient’s own body, enhanced in the laboratory, and then returned to the patient to fight cancer more effectively. These cellular therapies have shown remarkable responses in some blood cancers and are now being tested for solid tumors that have spread to other organs.^[13]

Metabolic therapies target the unique ways cancer cells process nutrients and energy. Cancer cells often rely on different metabolic pathways than normal cells to fuel their rapid growth. Scientists are developing drugs that interfere with these pathways, essentially starving cancer cells or making them more vulnerable to other treatments. Early clinical trials are testing whether blocking specific metabolic enzymes or pathways can slow cancer growth or enhance the effectiveness of existing therapies.^[7]

For hormone-sensitive cancers, newer generations of hormone-blocking drugs are in development. Oral selective estrogen receptor degraders, such as elacestrant, represent a new class of drugs that can be taken by mouth rather than requiring injections. These medications work by causing estrogen receptors on cancer cells to break down, preventing the cancer from responding to estrogen signals. Clinical trials have shown these drugs can benefit patients whose cancers have developed resistance to other hormone therapies.^[21]

CDK 4/6 inhibitors, mTOR inhibitors, and PIK3CA inhibitors represent targeted therapies that interfere with specific molecules involved in cancer cell growth and division. These drugs block signaling pathways that cancer cells use to multiply and survive. Combining these inhibitors with hormone therapy has shown improved outcomes in clinical trials for hormone receptor-positive breast cancer that has spread. Researchers continue testing these drugs in various combinations and in other cancer types.^[21]

For patients whose cancers have specific genetic mutations, PARP inhibitors offer a targeted treatment approach. These drugs work particularly well in cancers with BRCA1 or BRCA2 gene mutations by preventing cancer cells from repairing their damaged DNA. Clinical trials have demonstrated that PARP inhibitors can extend the time before cancer progresses in patients with ovarian, breast, prostate, and pancreatic cancers carrying these mutations.^[21]

Some research focuses on a concept called oligometastatic cancer, referring to situations where cancer has spread to only a few locations rather than extensively throughout the body. Clinical trials are testing whether directly treating these limited metastatic sites with surgery or focused radiation, in addition to systemic therapy, can improve outcomes and potentially even lead to long-term remission in selected patients. This approach challenges the traditional view that all metastatic cancer requires only systemic treatment.^[11]

Investigators are also studying drugs that target the tumor microenvironment – the normal cells, blood vessels, and other structures surrounding cancer cells. Cancer cells manipulate their environment to support their growth and protect themselves from the immune system. New experimental therapies aim to disrupt these supportive mechanisms, making it harder for cancer cells to thrive and easier for treatments to work. Some of these approaches prevent tumors from forming new blood vessels they need for growth, while others break down the physical barriers that keep drugs from reaching cancer cells.^[7]

Clinical trials are conducted at major cancer centers and research institutions around the world. Many trials operate at multiple sites, making it easier for patients to find a study location near them. The National Cancer Institute and other organizations maintain databases where patients and doctors can search for relevant clinical trials based on cancer type, stage, and other criteria.^[5]

Preliminary results from various clinical trials continue to generate optimism. Some experimental treatments have shown the ability to shrink tumors in patients whose cancers had progressed despite multiple previous therapies. Others have demonstrated improved survival times or better quality of life with fewer side effects than existing options. These encouraging signals guide researchers toward the next generation of cancer treatments, though many experimental therapies require further study before they can become widely available.^[13]

Most Common Treatment Methods

• Systemic Chemotherapy
  • Uses drugs that travel throughout the body to kill or slow the growth of cancer cells
  • Affects both cancerous and healthy rapidly dividing cells, causing side effects like nausea, fatigue, and hair loss
  • Specific drug combinations vary based on the type of cancer and where it started
  • May be given through an IV infusion or as oral pills, typically in cycles with rest periods between treatments
• Hormone Therapy
  • Used for cancers that depend on hormones to grow, such as certain breast and prostate cancers
  • Works by blocking hormone production or preventing hormones from reaching cancer cells
  • Often taken as daily pills for extended periods, sometimes years
  • May cause hot flashes, mood changes, fatigue, and bone density loss over time
• Targeted Therapy
  • Drugs that attack specific molecules or genetic changes found in cancer cells
  • More selective than chemotherapy, often causing fewer side effects
  • Includes CDK 4/6 inhibitors, mTOR inhibitors, PIK3CA inhibitors, and PARP inhibitors
  • Requires testing tumor tissue to identify specific targets before treatment
• Immunotherapy
  • Helps the patient’s immune system recognize and attack cancer cells
  • Has produced long-lasting responses in some patients with melanoma, lung cancer, and other types
  • Can cause side effects related to immune system overactivity, affecting organs like the lungs, liver, or intestines
  • Not effective for all patients; response varies based on cancer type and individual factors
• Radiation Therapy
  • Delivers focused radiation to specific tumor sites to shrink or control cancer growth
  • Particularly useful for bone metastases causing pain or risk of fractures
  • Can treat brain metastases to reduce symptoms like headaches or seizures
  • Modern techniques include stereotactic radiation that delivers high doses precisely to tumors
• Bone-Targeted Treatments
  • Bone-building medicines like bisphosphonates or denosumab strengthen bones and reduce fracture risk
  • Given as injections every few weeks
  • Help control bone pain from metastases
  • Radiopharmaceuticals deliver radiation directly to bone metastases throughout the body
• Antibody-Drug Conjugates
  • Combine targeted antibodies with chemotherapy drugs attached to them
  • Deliver chemotherapy directly to cancer cells while minimizing effects on healthy tissue
  • Examples include trastuzumab deruxtecan and sacituzumab govitecan
  • Showing promising results in clinical trials for various metastatic cancers

Living With Metastatic Cancer

Receiving a diagnosis of metastatic cancer changes everything. The initial shock, fear, and uncertainty can feel overwhelming. Many patients describe feeling disoriented, angry, or deeply sad when learning their cancer has spread. These emotional responses are completely normal and natural. Giving yourself time to process the news is important – there is no rush to make every decision immediately.^[15]

Over time, people living with metastatic cancer often find ways to adapt and maintain meaningful, fulfilling lives. Technological advances and new treatments mean that many patients now live for years with metastatic disease, viewing it more like a chronic condition that requires ongoing management rather than an immediate terminal diagnosis. Some cancers that once had limited treatment options now respond to therapies that can control the disease for extended periods.^[16]

Finding the right medical team makes a significant difference in the treatment journey. Patients should feel comfortable communicating openly with their doctors, asking questions, and participating in treatment decisions. If a particular doctor does not seem to have enough experience with metastatic cancer or does not communicate well, seeking a second opinion or finding a different oncologist is entirely appropriate. Treatment plans can and should be adjusted based on how well they work and how they affect quality of life.^[15]

Managing the practical aspects of life with metastatic cancer requires attention and planning. Regular medical appointments, imaging scans, blood tests, and treatments become part of the routine. Many patients experience what people call “scanxiety” – anxiety before and during the waiting period after scans to learn whether the cancer has grown or spread further. Acknowledging these feelings and finding ways to cope, whether through support groups, counseling, or stress-reduction techniques, helps maintain emotional well-being.^[16]

Financial concerns often weigh heavily on patients and families. Cancer treatment can be expensive even with insurance, and some patients find they cannot work as much or at all during treatment. Resources exist to help with financial challenges, including programs that assist with medication costs, transportation to appointments, and other expenses. Social workers at cancer centers can provide information about available assistance programs and help navigate insurance issues.^[16]

Connecting with others who understand what living with metastatic cancer means can provide tremendous support. Support groups, whether meeting in person or online, offer opportunities to share experiences, learn coping strategies, and feel less isolated. Seeing others who are managing their disease while continuing to work, travel, and enjoy time with family can provide hope and practical advice. Organizations dedicated to specific cancer types often facilitate support groups and online communities.^[15]

Physical well-being deserves attention alongside medical treatment. While energy levels may fluctuate during treatment, staying as active as possible within individual limitations helps maintain strength and can improve mood. Some patients find that yoga, meditation, or other mind-body practices help manage stress and treatment side effects. Nutrition also plays a role in maintaining strength and supporting the body during treatment, though specific dietary needs vary by individual.^[20]

Many people living with metastatic cancer find it helpful to set achievable goals, whether attending a child’s soccer game, planning a trip, or seeing a grandchild’s birth. These milestones provide something positive to focus on and remind patients they still have much to live for. Some days will naturally be better than others, and adjusting expectations based on how one feels on any given day is part of accepting the reality of living with cancer.^[19]

Family members and friends also face challenges when someone they love has metastatic cancer. They may struggle with their own fears and sadness while trying to provide support. Healthcare teams can provide resources for family members too, including counseling services and caregiver support groups. Open communication between patients and their loved ones about needs, feelings, and concerns helps everyone navigate this difficult journey together.^[18]

Hope remains important even when cure is unlikely. Hope can take different forms – hope for more good days, hope that treatments will work well with manageable side effects, hope for meaningful time with loved ones, or hope that new treatments in development will become available. Maintaining realistic optimism while accepting the situation as it is creates a foundation for living as fully as possible with metastatic cancer.^[19]